Concord Medical Declares Special Dividend of $0.33/Share, $0.99/ADS

Concord Medical Services Holdings Limited ("Concord Medical" or the "Company")

today announced that on December 11, 2015, its Board of Directors declared a special cash dividend of US$0.33 per ordinary share (or US$0.99 per American Depositary Share ("ADS")) on the Company's outstanding ordinary shares. The total expense for the special dividend is expected to be approximately US$44.5 million, based on 134,799,243 ordinary shares outstanding as of September 30, 2015. Each ADS represents three ordinary shares of the Company. The dividends are payable on or about January 30, 2016, to shareholders of record at the close of business on December 28, 2015. The ex-dividend date is expected to be on December 23, 2015. Dr. Jianyu Yang, Chairman and CEO of the Company, commented, "We are pleased that the Board of Directors declared this special dividend, which demonstrates our strong financial position. Concord Medical is well positioned to maintain its leadership position in the fast-growing healthcare services sector and establish a leading cancer hospitals network in China. The special dividend, together with our share buyback